UTHR — UNITED THERAPEUTICS CORP DEL

Ownership history in Scientech Research LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Scientech Research LLC reported a position in UNITED THERAPEUTICS CORP DEL (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.4% (2023 Q4)
Avg. % of fund
0.44%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,855 -1,292 -41.1% 0.57% $904K $487.25
2025 Q3 REDUCED 3,147 -3,004 -48.8% 0.46% $1.3M $419.21
2025 Q2 ADDED 6,151 +4,700 +323.9% 0.43% $1.8M $287.35
2024 Q4 ADDED 1,451 +158 +12.2% 0.14% $512K $352.84
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    UTHR price (monthly, adj. close)

Other funds also holding UTHR

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 15.71% Avoro Capital Advisors LLC 3Y 7Y 12.48% Tri Locum Partners LP 3Y 7.65% Nepsis Inc. 3Y 7Y 6.59% Eversept Partners, LP 3Y 7Y 6.2% Summit Street Capital Management, LLC 3Y 7Y 4.36% Polaris Capital Management, LLC 3Y 7Y 4.19% Nitorum Capital, L.P. 3Y 7Y 3.99% Palo Alto Investors LP 3Y 7Y 3.95% First Turn Management, LLC 3.54%
← Back to Scientech Research LLC Holdings